Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (296)	8/24/1999 12:10:00 AM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 1169

<<It shares no structural similarities with MPA, while it does inhibit the action of the same target enzyme. >> I thought that it have structural similarity with MPA! Please, help me save some time! Do you have chemical name or compounds-class group for VX-497? <<PS. I doubt this is driving the price action.>> As I said, it is only example to explain how regular investors and many analysts have serious shortfall when bt company is issue. They can't see further their nose and where is hidden real value. Miljenko PS. I am not trying to offend anyone or pretend that I am smart, but I do try to look few steps ahead and as a whole picture, not small peace or area (learned this from Japanese game GO).